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ABStrAct
A narrative review was conducted, drawing on peer reviewed literature and relevant 
grey literature on injecting drug use in African countries and ethical dilemmas facing 
harm reduction especially the provision of sterile needles and syringes to injecting drug 
users. This review aimed at highlighting evidence and the arguments for and against 
the provision of sterile injecting equipment to people who inject drugs (PWID), and to 
consider the implications for the African context. The narrative established that high risk 
injecting drug practices are common among PWID in many African communities, and so 
are HIV and hepatitis. Current services for this population in Africa are less pragmatic 
and inadequate. Needle and syringe programmes are both effective and ethical and 
should be part of the response to injecting drug use in Africa.
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introDuction
Needle and syringe programme (NSP) 
is among the 9 endorsed interventions by 
World Health Organization (WHO), United 
Nations Office on Drugs and Crime (UNO-
DC) and Joint United Nations Programme 
on HIV and AIDS (UNAIDS) as a part of the 
comprehensive package for prevention, 
treatment and care of HIV among injec-
tion drug users (WHO, 2009). According 
to several studies (Beckerleg, Telfer, and 
Hundt, 2005; McCurdy, Kilonzo, Williams, 
and Kaaya, 2007; Savanna, 2009) Africa 
continues to experience the unheeded 
spread of heroin and injecting drug use, 
particularly along the East African coast 
where heroin is trafficked from Pakistan 
and Afghanistan by sea. African states 
such as Kenya, Tanzania, Cote d’Ivoire, 
Mauritius, Morocco, Nigeria, Egypt, Mo-
zambique, South Africa, Ghana and the 
Democratic Republic of Congo have a 
documented growing burden of injecting 
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drug use. Of significant public health im-
portance is the rise in injecting drug use, 
usually without sterile injection equip-
ment, and sometimes with very high risk 
practices such as the deliberate shar-
ing of blood with fellow users who can-
not afford heroin, a practice called “flash 
blood” (Atkinson et al. 2011; McCurdy 
et al. 2007; Ross, McCurdy, Kilonzo, Wil-
liams, and Leshabari, 2008). In Kenya, 
the HIV prevalence was found to be six 
times higher amongst drug users who 
had shared needles compared to those 
who had not (National AIDS & STI con-
trol Program [NASCOP], 2012). In addi-
tion, Savanna (2009) notes that whereas 
some of Africa’s growing population of 
people who inject drugs (PWID) is largely 
unaware that sharing needles carries a 
risk of transmitting HIV; many of the AIDS 
prevention programs in the continent 
have perceived injection drug related HIV 
transmission as uncommon and thus not 
suitably addressed injection risks in their 
communications with the public. Mathers 
et al. (2010) and Savanna (2009) also note 
that only few countries have implement-
ed HIV prevention and care programmes 
specifically for PWID in Sub-Saharan Af-
rica. See Table 1 for a summary of inject-
ing drug use, HIV, hepatitis and NSP data 
in selected high prevalence countries in 
Africa. The statistics in Table 1 illustrate 
the unmet need for adequate services 
among PWIDs. In one of the large stud-
ies including some African states, NSPs 
were absent or unreported among 14 of 
the 16 countries in sub-Saharan Africa 
where injecting drug use occurs (Mathers 
et al. 2010). In addition, where some of 
the NSP were present, the rates of dis-
tribution were as low as 0·1 needle–sy-
ringes per person injecting drugs per year. 
Mathers et al. (2010) also established 
that the number of PWID receiving anti-
retroviral therapy (ART) relative to the es-
timated number of PWID living with HIV 
varied greatly, from as low as less than 
one recipient per 100 HIV-positive inject-
ing drug users. The prevailing low ac-
cess to NSP among most IDUs in African 
communities still makes it challenging to 
ascertain the overall impact of the NSP; 
however, there are already documented 
benefits for those receiving these servic-
es as discussed further in this article. Kelly 
et al. (2006) also notes that the majority 
of the organizations working in HIV treat-
ment and prevention in Africa were most 
likely to target the general population and 
youth with a more generalized heterosex-
ual epidemic perspective which as a result 
widely excludes special groups such as 
PWID. According to Kelly et al. (2006) and 
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table 1. NSP coverage, injecting drug use, and related disease prevalence in selected 
sub-Saharan African countries 
country Population 
of PWiD1 
% of hiV 
among PWiDa




% of Hepatitis C 
among PWiD3
Kenya 30,000 36-43 6.1 - 42.2-60.6
Mauritius 10,000 47.4 1.2 51.9 97.3
Nigeria - 8.9 3.1 - -
South Africa 67,000 19.4 17.9 - -
Tanzania 25,000-50,000 42 5.1 - 22.2
Sources: Peter, Myers, vanHout, Pluddeman & Parry (2013); bAIDSinfo (2012); cIHRA (2013)
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Todd, Nassiramanesh, Stanekzai, & Kama-
rulzaman, (2007) some of the barriers to 
equitable or comprehensive programme 
implementation include: governmental 
indifference or opposition, stigma, pub-
lic discomfort and religious beliefs. The 
lack of mandate from some African gov-
ernments on acceptable ways to address 
problems faced by PWID is still a barrier 
to comprehensive programming (Klein 
(2011); McCurdy et al. 2007). In addition, 
existing policies, regulations and strate-
gies are not conducive for implementa-
tion of evidence-informed interventions 
such as NSP (NASCOP, 2012). Much as 
drug use prevention is important, the 
“war on drugs” in some countries like Tan-
zania has been characterized as having 
accompanying policy that inadequately 
focuses on the needs of the communities 
and the drug users themselves (McCurdy 
et al. 2007). 
Therefore, the inadequate coverage 
of needle syringe programmes in most 
African states sets center stage for the 
need to explore the commonly associated 
fears among the general public and policy 
makers from around the world. There is 
as well need to elaborate on the ben-
efits and ethics point of view in support 
of needle and syringe programmes and 
harm reduction in general.
MethoD
A narrative review was conducted, 
drawing on peer reviewed literature and 
relevant grey literature on injecting drug 
use in African countries and ethical dilem-
mas facing harm reduction especially the 
provision of sterile needles and syringes 
to injecting drug users. The search terms; 
(Africa) AND needle exchange were used 
in PubMed to generate most of the peer 
reviewed articles used in this narrative. 
However, these were supplemented by 
literature from other relevant peer re-
viewed articles on ethics of NSP and from 
reports and internet sources of reputable 
actors in this field such as WHO, UNAIDS, 
UNODC, International Harm Reduction 
Association and government ministries.
DiScuSSion
What kind of opposition prevails against 
needle and Syringe Programmes?
The controversy on needle and syringe 
programmes (NSPs) has been mainly fu-
eled by the notion of whether a person 
who uses drugs should be seen as a pa-
tient or a criminal, and whether it is 
ethical or lawful to provide a person us-
ing drugs the means to inject (Tempal-
ski et al. 2007). The criminalization of 
drug use, which sometimes also involves 
criminalizing the possession of injection 
equipment, has been found to cause ten-
sion between the PWID, the NSP service 
providers and police (Klein, 2011; Shaw, 
2006). Intense policing and criminaliza-
tion of drug possession and use poten-
tially worsens the risky injection practices 
among PWID (Klein, 2011) as also was 
the case observed in Tanzania (McCurdy 
et al., 2007). In addition, Savanna (2009) 
and Klein (2011) observe that criminaliza-
tion has driven PWID underground thus 
making this population hard to reach on 
the streets. Also, due to increased rates 
of incarceration, an increase in injecting 
drug use has been reported in African 
prisons in Kenya, Cote d’Ivoire, Mauri-
tius and Ghana (NASCOP, 2012; Savanna, 
2009). In addition, the lesson that should 
be drawn from the high recidivism rate of 
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ex-prisoners after release from jail is that 
the law enforcement approach through 
punishment by incarceration of criminals 
(drug users) will not be effective either in 
preventing drug use in communities or in 
preventing the spread of HIV and hepati-
tis through unsterile injection equipment 
(Visher &Travis, 2003). 
One solution that has been used exten-
sively in other regions with high rates of 
injecting drug use is through pragmatic 
approaches such as the inclusion of NSPs 
in the continuum of services for people 
who use drugs. Shaw (2006) explains that 
usually the opponents of NSPs greatly 
support drug treatment programmes that 
are based on abstinence and ‘‘drug-free’’ 
treatment for addiction. The WHO (2006) 
explains that this is because many NSP 
opponents wrongly perceive that harm 
reduction opposes abstinence based ap-
proaches or even condones drug use but 
contrary to their views, abstinence is on 
the same spectrum as harm reduction, 
with harm reduction being the first step 
towards being abstinent and healthy for 
many people who use drugs. Adding more 
to the opponents’ views, some argue that 
providing sterile needles to PWID sends 
conflicting signals to the clients of ad-
diction treatment programmes (Shaw, 
2006; WHO, 2006). In reality, most clini-
cal services are skilled in dealing with the 
simultaneous and seemingly contradic-
tory desires in their patients by explicitly 
encouraging abstinence and avoidance of 
harm. If we look close enough, most of us 
are also full of simultaneously held seem-
ingly contradictory desires (Zhang, Yap, 
Xun, Wu, and Wilson, 2011). As a result of 
integration of harm reduction in services 
delivered by “We Help Ourselves”; a lo-
cal organization in Australia (WHO, 2006), 
there were observed improvements in 
client retention and completion of reha-
bilitation programme. There were also 
reductions in risky sex behaviour among 
the clients. In addition several other ben-
efits of NSPs include; improved entry to 
primary health care and drug treatment, 
plus prevention of other blood borne and 
viral or bacterial infections (WHO, 2004). 
Contrary to opponents’ fears and beliefs, 
WHO (2004) notes that there is not so 
far convincing scientific evidence of un-
intended complications of NSPs such as 
greater injection frequency, increased il-
licit drug use, recruitment of new PWID, 
greater number of discarded needles and 
less motivation among PWID to reduce 
drug use. 
The opponents of NSPs have furthered 
expressed concerns that NSPs are expen-
sive programmes. Shaw (2006) also notes 
that others have unfair, judgmental views 
about addiction. As an example, a protest 
against NSPs in Springfield, USA involved 
opponents expressing a concern that tre-
mendous financial resources (tax payers’ 
money) would be spent on NSPs and yet 
addiction is a personal choice in which 
the drug users should be held responsible 
for its consequences (Shaw, 2006). On 
the contrary, NSPs have been shown to 
be a cost effective way of preventing HIV 
in other low income settings, particularly 
when started early and with adequate 
availability (Zhang et al., 2011). Further-
more, to deny access to needles on the 
basis that people should not be injecting 
is like banning seat belts on the basis that 
if people drove carefully there would be 
no accidents. 
Furthermore, some NSP opponents 
fear that by opening NSPs their com-
munities will be represented as plagued 
by AIDS and drug use (Shaw, 2006). In 
addition, there are many examples of 
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political interference that hinders the 
desirable progress of NSPs (Buchanan, 
Shaw, Ford, and Singer, 2003). Similarly, 
according to McCurdy (2007) and Klein 
(2011), in some African countries there 
has been the lack of a clear mandate 
from governments on acceptable ways 
to address problems faced by PWID. In 
addition to lack of government mandate, 
some critics are skeptical of their govern-
ments’ commitment in properly imple-
menting NSPs (Voice of America, 2012). 
From elsewhere in the world, political 
suppression has been echoed through 
negative comments on NSPs from influ-
ential leaders such as: the former gov-
ernor of New Jersey Christine Whitman, 
former US president George W. Bush and 
Reverend Michael Orsi (Buchanan et al., 
2003). Such negative publicity plays a 
role in stigmatizing NSP.
What ethical basis supports the 
implementation of needle and syringe 
programmes (nSPs)?
Social justice (fairness): The principle of 
justice and fairness mandates that ben-
efit and burdens are equitably distribut-
ed with in a community (Loue, Lurie and 
Lloyd, 1995). Therefore people who inject 
drugs and those who are related to them 
such as co-users, sex partners, parents, 
friends or children deserve the equal 
protections through needle and syringe 
services to prevent the potential harms 
and risk to their lives (Iozzio, 2011). How-
ever, in comparison to other concerns, 
drug dependence treatment needs and 
services have always been allocated inad-
equate resources. For instance, according 
to Mathers et al. (2010) worldwide, the 
proportion of HIV positive PWID receiving 
ART was estimated at 4%, as compared to 
40% for the non drug using population. 
This neglect for drug dependence treat-
ment is attributable to society’s preju-
dice which is contrary to the principles 
of justice and fairness (Loue et al. 1995). 
In addition, there is usually a divide be-
tween the active citizens who participate 
in shaping government/society decisions 
and the group of marginalized individuals 
(PWID) that are bound together by their 
experience of drug use and HIV (Shaw, 
2006). 
Utilitarianism: When considering the al-
location of resources for public health, 
the right choice is often considered as the 
one that produces the most gain for the 
most people, for instance, the greatest re-
duction in the burden of disease (Roberts 
and Reich, 2002). In support of utilitari-
anism, the beneficence and non-malef-
icence of NSPs are demonstrable by the 
variety of benefits (Bastos and Strathdee, 
2000; Voice of America, 2012) that PWID 
receive from these services. Furthermore, 
NSPs are beneficial to non-injecting drug 
users as well since they reduce transmis-
sion of HIV to PWIDs’ sexual partners and 
to new born infants (Iozzio, 2011; Loue et 
al. 1995). Also, extra services such as legal 
support systems provided through NSPs 
among PWID are essential in combating 
crime resulting from drug dependency 
(Klein, 2011; Shaw, 2006). 
human rights: Liberal egalitarians state 
that everyone has a positive right to the 
minimum level of services and resources 
needed to assure minimum quality and 
quantity of life and thus to health care 
needed to guarantee that minimum 
(Roberts and Reich, 2002). This therefore 
entitles PWID to a comprehensive pack-
age of care endorsed by UNODC, WHO 
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and UNAIDS for addressing blood borne 
infections among this group. In addition, 
Iozzio (2011) notes that the provision 
of NSPs is a common good and a sign of 
respect and ensures that IDUs and their 
families are treated with dignity and with 
sensitivity to cultural, racial, ethnic and 
gender-based differences. Furthermore, 
NSPs respect PWID by helping them to 
make healthy choices such as use of ster-
ile needles instead of unsafe, contami-
nated ones (Loue et al. 1995). Further-
more, the same author explains that NSPs 
observe human rights through respect 
for PWID by increasing their access to 
primary health care and as well through 
ensuring high level confidentiality during 
service delivery.
communitarianism: The philosophy of 
communitarianism aims at creating a 
good society by grooming individuals for 
that society (Roberts & Reich, 2002). Re-
ligious and moralistic approaches largely 
dwell on this ideology. Todd et al., 2007 
emphasizes that if there is continued 
involvement of the religious commu-
nity, their focus should be on supporting 
treatment rather than punishment and 
this will be a key factor in acceptability 
of NSPs. In Kenya for instance, punish-
ment of drug users through incarceration 
has proved inadequate since there are 
few biological and behavioural interven-
tions in prisons to deter inmates from 
drug use and other risky practices while 
in prison (NASCOP, 2012). Indeed, there 
are also many different views about what 
constitutes individual and social virtue 
(Roberts & Reich, 2002). Much as local 
approval is fundamental in the establish-
ment of NSPs, there are often situations 
in which decision makers are intimidated 
and forced to pick sides that may not 
necessarily represent the interests and 
needs of the community (Shaw, 2006). 
Additionally, there exists a challenge in 
defining who should constitute the local 
approval. However, there exists a sharp 
contrast between relativist communitar-
ians and universalist communitarians 
(Robert & Reich, 2002). The relativists 
view morality as entirely contextual while 
the latter argue that access to proper 
health should be promoted in all com-
munities regardless local cultural norms. 
Therefore, it is imperative for the NSP 
opponents to embrace the moral realism 
notion which according to Roberts and 
Reich (2002) emphasizes that morality 
can be learnt by understanding human 
nature and analyzing human needs plus 
requirements of social life.
concluSion
Access to clean injecting equipment 
has not been achieved in most develop-
ing communities, even those with docu-
mented injecting drug use (Beckerleg et 
al., 2005; NASCOP, 2012). People who 
use drugs in developing communities 
continue to ask for assistance from their 
governments, key stakeholders and ac-
tors. There is an unmet demand for a 
greater access to services including NSP 
(Klein, 2011; Atkinson et al., 2011; Mc-
Curdy et al., 2007). In preventing the 
spread of HIV, including in Africa, high risk 
groups for injecting transmission (PWID) 
need to be acknowledged and targeted 
for outreach (Atkinson et al., 2011; Sa-
vanna, 2009). Despite arguments to the 
contrary, the existing scientific evidence 
and a broad consideration of ethical prin-





AIDSinfo. (2012). Epidemiological status. 
Retrieved October 30, 2013, from 
http://www.unaids.org/en/dataanal-
ysis/datatools/aidsinfo/.
Atkinson, J., McCurdy, S., Williams, M., 
Mbwambo, J., & Kilonzo, G. (2011). 
HIV risk behaviours, perceived sever-
ity of drug use problems and prior 
treatment experience in a sample 
of young heroin injectors in Dar es 
Salaam, Tanzania. African Journal of 
Drug & Alcohol Studies, 10(1), 1-9.
Bastos, FI., & Strathdee, S.A. (2000). 
Evaluating effectiveness of syringe ex-
change programmes: current issues 
and future prospects. Social science & 
medicine, 51 (12), 1771-1782.
Beckerleg, S., Telfer, M., & Hundt, GL. 
(2005). The rise of injecting drug use 
in East Africa: a case study from Ke-
nya. Harm Reduction Journal, 2(1), 
12. 
Buchanan, D., Shaw, S., Ford, A., & Singer, 
M. (2003). Empirical science meets 
moral panic: an analysis of the politics 
of needle exchange. Journal of Public 
Health Policy, 24 (3), 427-444.
International Harm Reduction Association 
, IHRA. (2013). Sub-Saharan Africa- 
Regional Overview Retrieved October 
31, 2013 from http://www.ihra.net/
fr/print/sub-saharan-africa.
Iozzio, M.J. (2011). Needle Exchange: The 
Moral Framework for a Global Prob-
lem. Health Progress, 92 (6), 64-67.
Kelly, J. A., Somlai, A. M., Benotsch, E. G., 
Amirkhanian, Y. A., Fernandez, M. 
I., Stevenson, L. Y. et al. (2006). Pro-
grammes, resources, and needs of 
HIV-prevention nongovernmental or-
ganizations (NGOs) in Africa, Central/
Eastern Europe and Central Asia, Lat-
in America and the Caribbean. Aids 
Care, 18 (1), 12-21.
Klein, A. (2011). Harm reduction- the right 
policy approach for Africa? African 
Journal of Drugs & Alcohol Studies, 
10(1), 59-69.
Loue, S., Lurie, P., & Lloyd, L.S. (1995). Eth-
ical issues raised by needle exchange 
programs. Journal of the American 
Society of Law, Medicine & Ethics, 23 
(4), 382-388.
Mathers, BM., Degenhardt, L., Ali, H., Wi-
essing, L., Hickman, M., Mattick, R.P., 
et al. (2010). HIV prevention, treat-
ment, and care services for people 
who inject drugs: a systematic review 
of global, regional, and national cov-
erage. Lancet, 375 (9719), 1014-1028.
McCurdy, S., Kilonzo, GP., Williams, & 
M., Kaaya, S. (2007). Harm reduc-
tion in Tanzania: an urgent need for 
multisectoral intervention. The Inter-
national Journal on Drug Policy, 18 
(3),155-159.
National AIDS & STI control Program , 
NASCOP. (2012). MARPs surveillance 
report. Nairobi, Kenya: Ministry of 
Health. 
Petersen, Z., Myers, B., vanHout, MC., 
Pluddemann, A., & Parry, C. (2013). 
Availability of HIV prevention and 
treatment services for people who in-
ject drugs: findings from 21 countries. 
Harm Reduct Journal, 10(1), 13. 
Roberts, M.J., & Reich M. R. (2002). Ethi-
cal analysis in public health. Lancet, 
359 (9311), 1055-1059.
Ross, M., McCurdy, S., Kilonzo, G., Wil-
liams, M., & Leshabari M. (2008). 
Drug use careers and blood-borne 
pathogen risk behavior in male and 
female Tanzanian heroin injectors. 
American Journal of Tropical Medi-
cine and Hygiene, 79, 338-343.
NEEDLE AND SYRINGE PROGRAMMES IN AFRICA
144
Savanna, R.R. (2009). Injection drug use, 
unsafe medical injections, and HIV in 
Africa: a systematic review. Harm Re-
duction Journal, 6(1), 24. 
Shaw, S. (2006). Public Citizens, Margin-
alized Communities: the struggle for 
syringe exchange in Springfield, Mas-
sachusetts. Medical Anthropology, 25 
(1), 31-63.
Tempalski, B., Flom, PL., Friedman, SR., 
DesJarlais, D.C., Friedman, J.J., & 
McKnight, C. (2007). Social and Politi-
cal Factors Predicting the Presence of 
Syringe Exchange Programs in 96 US 
Metropolitan Areas. American Jour-
nal of Public Health, 97 (3), 437-447.
Todd, C.S., Nassiramanesh, B., Stanekzai, 
M.R., & Kamarulzaman, A. (2007). 
Emerging HIV epidemics in Muslim 
countries: assessment of different 
cultural responses to harm reduction 
and implications for HIV control. Cur-
rent HIV/AIDS Reports, 4 (4), 151-157.
Visher, C.A., & Travis, J. (2003). Transitions 
from prison to community: Under-
standing individual pathways. Annual 
review of sociology, 29, 89-113.
Voice of America. (2012). Kenyan Needle 
Exchange Program faces opposition. 





World Health Organization. (2004). Effec-
tiveness of sterile needle and syringe 
programming in reducing HIV/AIDS 
among injecting drug users (Evidence 
for action technical papers). Geneva: 
WHO.
World Health Organization Regional Of-
fice for the Western Pacific. (2006). 
The Integration of Harm Reduction 
Into Abstinence-Based Therapeutic 
Communities: A Case Study of We 
Help Ourselves, Australia. Geneva: 
WHO.
World Health Organization. (2009). WHO, 
UNODC, UNAIDS Technical guide for 
countries to set targets for universal 
access to HIV prevention, treatment 
and care for injecting drug users. Ge-
neva: WHO.
Zhang, L., Yap, L., Xun, Z., Wu, Z., & Wil-
son, D.P. (2011). Needle and syringe 
programs in Yunnan, China yield 
health and financial return. BMC Pub-
lic Health, 11(1), 250.
DERRICK
